Protara Therapeutics, Inc. (TARA) › Net IncomeProtara Therapeutics, Inc. (TARA) — Net IncomeAnnual figures by period end, from SEC filings.2012-12-31: -$7.97M2013-12-31: -$7.91M2014-12-31: -$3.34M2015-12-31: -$21.38M2016-12-31: -$28.53M2017-12-31: -$29.96M2018-12-31: -$20.73M2019-12-31: -$7.83M2020-12-31: -$33.98M2021-12-31: -$47.25M2022-12-31: -$65.95M2023-12-31: -$40.42M2024-12-31: -$44.60M2025-12-31: -$57.44M-$57.44M2012-12-31Net Income (USD)2025-12-31Period endedNet IncomeChange YoYSource filing2025-12-31-$57.44M—2026-03-10From 2025-01-012024-12-31-$44.60M—2026-03-10From 2024-01-012023-12-31-$40.42M—2025-03-05From 2023-01-012022-12-31-$65.95M—2024-03-13From 2022-01-012021-12-31-$47.25M—2023-03-08From 2021-01-012020-12-31-$33.98M—2022-03-09From 2020-01-012019-12-31-$7.83M—2021-03-11From 2019-01-012018-12-31-$20.73M—2020-03-20From 2018-01-012017-12-31-$29.96M—2019-03-13From 2017-01-012016-12-31-$28.53M—2019-03-13From 2016-01-012015-12-31-$21.38M—2018-03-14From 2015-01-012014-12-31-$3.34M—2017-03-16From 2014-01-012013-12-31-$7.91M—2016-03-14From 2013-01-012012-12-31-$7.97M—2015-03-20From 2012-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)